Study reveals that coffee consumption is associated with a reduced risk of developing irritable bowel syndrome (IBS), as determined by a systematic review and meta-analysis of global studies.
With expectations rising, Corbus reveals new data on its ADC bladder cancer treatment
CHICAGO — Corbus Pharmaceuticals is the second best-performing biotech stock this year, thanks to investor interest in an antibody-drug conjugate candidate, or ADC, called CRB-701
June 1, 2024